Skip to product information
1 of 1

Elabscience

SKU:E-EL-R0532

Rat IGFBP-2(Insulin-like Growth Factor Binding Protein 2) ELISA Kit

Rat IGFBP-2(Insulin-like Growth Factor Binding Protein 2) ELISA Kit

Regular price $609.00 USD
Regular price Sale price $609.00 USD
Sale Sold out
Shipping calculated at checkout.
Size
The RAT IGFBP-2 (Insulin-like Growth Factor Binding Protein 2) ELISA Kit is a highly reliable and efficient tool designed for the quantitative measurement of IGFBP-2 levels in rat samples. This ELISA kit utilizes a sandwich enzyme immunoassay technique, ensuring accurate and precise results. IGFBP-2 is a crucial protein involved in the regulation of insulin-like growth factors (IGFs), which play a vital role in cell growth, differentiation, and development.

This ELISA kit offers a user-friendly and straightforward protocol, making it suitable for both experienced researchers and beginners. The kit includes all the necessary components, such as pre-coated microplates, standards, controls, and reagents, ensuring convenience and ease of use. The assay is performed by adding the sample and the provided biotin-conjugated antibody to the microplate wells, allowing the IGFBP-2 present in the sample to bind to the immobilized antibody. After a washing step to remove any unbound substances, a streptavidin-HRP conjugate is added, which binds to the biotin-conjugated antibody. Finally, a substrate solution is added, and the color development is measured spectrophotometrically, providing accurate and quantitative results.

With a wide dynamic range and high sensitivity, the RAT IGFBP-2 ELISA Kit enables the detection of IGFBP-2 levels as low as 0.156 ng/mL. This kit offers excellent reproducibility and precision, ensuring reliable and consistent results. It is suitable for various rat sample types, including serum, plasma, and tissue homogenates. The RAT IGFBP-2 ELISA Kit is an essential tool for researchers studying the role of IGFBP-2 in various physiological and pathological processes, such as growth disorders, cancer, and metabolic diseases.
View full details